ArticleInternational journal of clinical oncology2026

How should we interpret the use of vonoprazan and proton pump inhibitors during immunotherapy for hepatocellular carcinoma?

Hongru Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.